Clinical trials
Phase 4 Essential Hypertension trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Pavia | 2 |
| Chinese Academy of Medical Sciences, Fuwai Hospital | 1 |
| Chong Kun Dang Pharmaceutical | 1 |
| Erasmus Medical Center | 1 |
| Pacific Pharmaceuticals | 1 |
| Radboud University Medical Center | 1 |
| Seoul National University Bundang Hospital | 1 |
| Shanghai Shyndec Pharmaceutical Co., Ltd. | 1 |
| Sichuan Academy of Medical Sciences | 1 |
| Third Military Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Essential Hypertension | 15 |
| Hypertension | 4 |
| Coronary Disease | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Fatty Liver | 1 |
| Hypercholesterolemia | 1 |
| Kidney Diseases | 1 |
| Metabolic Syndrome | 1 |
| Multiple Endocrine Neoplasia Type 1 | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.